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OBJECTIVE: The aim of the study was to analyze the relationship between gait speed and measurements of
physical function in patients with symptomatic peripheral artery disease (PAD).
METHODS: One hundred sixty-nine patients (age 66.6±9.4 years) with symptomatic PAD were recruited. Usual
and fast gait speeds were assessed with a 4-meter walk test. Objective (balance, sit-to-stand, handrip strength,
and six-minute walk test) and subjective (WIQ – Walking Impairment Questionnaire and WELCH – Walking
Estimated-Limitation Calculated by History) measurements of physical function were obtained. Crude and
adjusted linear regression analyses were used to confirm significant associations.
RESULTS: Usual and fast gait speeds were significantly correlated with all objective and subjective physical
function variables examined (ro0.55, po0.05). In the multivariate model, usual gait speed was associated with
six-minute walking distance (b=0.001, po0.001), sit-to-stand test score (b=-0.005, p=0.012), and WIQ stairs score
(b=0.002, p=0.006) adjusted by age, ankle brachial index, body mass index, and gender. Fast gait speed was
associated with six-minute walking distance (b=0.002, po0.001), WIQ stairs score (b=0.003, p=0.010), and
WELCH total score (b=0.004, p=0.026) adjusted by age, ankle brachial index, body mass index, and gender.
CONCLUSION: Usual and fast gait speeds assessed with the 4-meter test were moderately associated with
objective and subjective measurements of physical function in symptomatic PAD patients.
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’ INTRODUCTION
Intermittent claudication is the most common symptom
of peripheral artery disease (PAD), affecting approximately
2% of the general population (1). Walking impairment has
been related to quality of life (2), physical fitness and car-
diovascular function in symptomatic PAD patients (3,4).
In addition, pain during walking has been considered an
important barrier for physical activity practice (5). Therefore,
assessment of physical function has been considered a main
outcome in patients with symptomatic PAD.
The progressive graded treadmill test and six-minute walk
test (6MWT) have been frequently used to assess physical
function in patients with symptomatic PAD (6,7). However,
the graded treadmill test and six-minute walk test usually
require a specific professional (physician or exercise physiol-
ogist) and adequate device (treadmill) or specific location
(30-meter corridor). In addition, some patients have difficul-
ties performing treadmill exercise (8), and some learning
effects can occur, especially in the 6MWT (9). All these factors
limit the objective physical function assessment in vascular
clinical practice (7).
Gait speed assessed during a 4-meter walk is simple, quick,
reproducible (10), and inexpensive and has emerged as an
important tool for physical function assessment in the elderly
population. In this age group, gait speed is a strong predictor of
functional decline (11) and mortality (12). This test has also been
used in symptomatic PAD patients, showing associations with
functional decline (12) and quality of life (13). Chen et al. (14)
observed that gait speed assessed with the 4-meter walk test is a
strong predictor of 6MWT performance in a multivariate model,
indicating the potential use of this test as an indicator ofDOI: 10.6061/clinics/2019/e1254
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functional capacity. However, whether gait speed can be used as
a stand-alone indicator of physical function is unknown.
In this study, we analyzed the relationship between gait
speed assessed with a 4-meter test in two conditions, usual
and fast pace, with objective and subjective measurements of
physical function in symptomatic PAD patients.
’ MATERIAL AND METHODS
Experimental approach to the problem
To analyze the relationship between gait speed and
physical function in a cross-sectional study, we recruited
patients with PAD and symptoms of intermittent claudica-
tion. The sample size to achieve significance in correlations
X0.25, considering an alpha error of 0.05 and a power of
80%, was estimated to be 123 patients. The patients were
submitted to an assessment of their gait speed through the
4-meter walk test, which was performed in two conditions:
usual pace and fast pace. To assess physical function, a 6MWT,
handgrip strength test, static balance test and sit-to-stand test
were performed. Patients also answered two specific ques-
tionnaires (Walking impairment questionnaire – WIQ and
Walking Estimated-Limitation Calculated by History –
WELCH) to assess their self-reported physical function.
Associations between gait speed (usual and fast pace) with
objective and subjective measures of physical function
were assessed through multiple linear regression analysis.
Patients
Symptomatic PAD patients were recruited at hospitals in
São Paulo, Brazil, between September 2015 and March 2018.
The inclusion criteria were as follows: a) aged 50 years or
older with presence of intermittent claudication symptoms
(Rutherford stages II and III in one or two legs; b) ankle
brachial index (ABI)o0.90; c) absence of critical limb ischemia,
rest pain, noncompressible vessels, amputated limbs and/or
ulcers, and d) absence of pulmonary diseases.
The study was approved by the Institutional Review
Board, performed in accordance with the International Ethics
Standards, conformed to the Helsinki Declaration, and
approved by the Institutional Ethics Committee.
Prior to data collection and participation, patients were
informed about the procedures for participation in the study,
as well as the risks and benefits, and signed a written infor-
med consent form.
Sociodemographic, comorbidities, and medication informa-
tion were obtained through a face-to-face interview. Socio-
demographic variables included age, sex (male or female),
and educational status (incomplete high school, high school
or more). History of smoking habits (ex-, current, or never-
smoker), obesity (body mass index (BMI) X30 kg/m2),
diabetes (doctor-diagnosed or use of glucose-lowering
drugs), hypertension (systolic/diastolic blood pressure
X140/90 mmHg or use of antihypertensive drugs), dysli-
pidemia (doctor-diagnosed or use of lipid-lowering drugs),
coronary heart disease, heart failure, and cerebrovascular
disease (medical history) were obtained. Body weight was
measured via a calibrated scale to the nearest 0.1 kilogram,
while height was measured with a stadiometer to the nearest
0.01 m. BMI was calculated as body weight divided by height
squared in meters.
PAD severity was identified by a single evaluator using
the ABI in accordance with guidelines (15). Briefly, ABI was
measured as the highest systolic blood pressure in the
posterior tibial or dorsalis pedis artery divided by the highest
systolic blood pressure in the brachial artery. Blood pressure
measurements were recorded in both limbs using a Doppler
vascular monitor (Medmega DV160, Brazil) and a mercury
sphygmomanometer.
Gait speed test
To analyze gait speed, we assessed patients on a 4-meter
test. Patients performed this test twice (usual and fast gait)
over four meters, and the time was recorded using a
stopwatch (within 0.1 seconds). To assess the usual gait
speed, patients were instructed to ‘‘walk to the other end of
the course at your usual speed, just as if you were walking
down the street to go to the store.’’ To assess the fast gait
speed, patients were instructed to walk as fast as they could
until the end of the course. Patients were allowed to use
assistive devices if needed, and each participant was timed
for two attempts at usual and fast gait speeds. The fastest
walk of each pair of attempts (usual and fast) was used for
analyses. To describe the gait speed, a ratio between distance
(4-meter) and the time that the patient took to complete the
course was calculated.
Objective measurement of physical function
Handgrip strength was obtained using a dynamometer
with digital display (CAMRY, USA) that was adjustable and
calibrated with a scale from 0 to 100 kgf. Patients remained
seated with a slight adduction of the shoulder, the elbow
flexed at 90o, and the forearm and wrist in a neutral position.
The test was performed in three attempts for both arms.
In each attempt, patients performed a maximal voluntary
contraction for five seconds, with a 1-minute interval between
each attempt.
The standing balance test required patients to maintain for
10 seconds each stance, with their feet placed side by side,
semitandem, and in tandem. For each stance, the interviewer
first demonstrated the task, then supported patients to
maintain their balance while they positioned their feet, asked
if they were ready, released the support and began timing.
The timing was stopped when participants moved their feet
or grasped the interviewer for support or when 10 seconds
had elapsed. Scores ranged from 0 to 4 (maximum per-
formance).
The sit-to-stand test required patients to stand from a chair
with their arms across their chest, five times, as quickly as
possible, the task was timed from the initial sitting position
to the final standing position at the end of the fifth stand. The
time measured in seconds was the outcome.
Patients also performed an over-ground 6MWT along a
30-m-long corridor as previously described (16). Briefly,
patients were encouraged to ‘‘walk at their usual pace for six
minutes and cover as much ground as possible’’ and rest if
necessary. At the end of each minute, patients received
feedback on the elapsed time, and standardized encourage-
ment in the form of statements such as ‘‘you’re doing well,
keep it up’’ and ‘‘do your best‘‘ were utilized. The total
walked distance was defined as the maximum distance
completed by the patient at the end of six minutes.
Subjective measurement of physical function—
Questionnaires
Subjective physical function was measured by valida-
ted versions of the WIQ (17) and WELCH questionnaire (18).
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The WIQ assesses self-reported ambulatory ability in 3
domains: walking distance, walking speed, and stair climb-
ing, with each domain scored on a 0 to 100 scale, where
0 represents extreme limitation and 100 represents no diffi-
culties walking long distances, walking rapidly, or climbing
3 stair flights, respectively. The WELCH questionnaire (18) is
a four-question questionnaire related to the speed at which
the patient walks normally. The WELCH score ranges from
0 to 100, with zero indicating a patient who can only walk for
30 seconds when walking slowly and who usually walks
much slower than relatives, friends or people of the same age
without PAD. A score of 100 refers to a patient who can walk
3 hours or more, even when walking fast, and who usually
walks faster than relatives, friends or people of the same age
without PAD.
Statistical analysis
The Gaussian distribution and the homogeneity of variance
of the data were analyzed by Shapiro-Wilk and Levene tests.
Associations between gait speed (usual and fast pace) with
physical function (balance, sit-to-stand test, handgrip strength
and 6MWT) and subjective physical function (WIQ and
WELCH) were assessed through multiple linear regression
analysis. Within these models, variables with known associa-
tions to either dependent or independent variables were
chosen a priori and included as covariates to the regression
model. Covariates included age, ABI, BMI, and gender.
A residual analysis was performed with homoscedasticity
examined using graphical analysis (scatter plot) and the
Cook-Weisberg test. Multicollinearity was assessed assuming
a variance inflation factor below 5.0. The unstandardized
coefficients (standard error), coefficient values, and signifi-
cance were determined in the regression models. All analyses
were performed using IBM SPSS Statistics, version 20.0, and
the level of significance was set at po0.05 (2-tailed).
’ RESULTS
One hundred sixty-nine patients were included in the
study, and their clinical characteristics and objective and
subjective physical function are shown in Table 1. The
mean ABI reflects moderate severity of the disease (ABI:
0.58±0.16). Most of the patients presented with associated
risk factors such as hypertension (85%), dyslipidemia (78%)
and diabetes mellitus (52%).
Table 2 shows the correlations between gait speed (4-meter
usual and fast pace) tests with objective and subjective
measurements of physical function. Usual and fast gait
speeds were significantly correlated with all objective and
subjective physical function variables. There were no cor-
relations between usual gait speed and BMI (p40.417) or
between the 4-meter tests and ABI (p40.236). Fast gait speed
was not correlated with age (p=0.064).
Table 3 shows the results of the adjusted linear regression
analysis for the association between gait speed (4-meter
usual and fast pace) and objective and subjective measure-
ments of physical function. After adjustments for age, ABI,
BMI and gender, the usual gait speed presented associa-
tions with the 6MWT (b=0.001, po0.001), sit-to-stand test
(b=-0.005, p=0.012), and WIQ stairs (b=0.002, p=0.006) scores.
After adjustments for age, ABI, BMI, and gender, the fast gait
speed was associated with the 6MWT (b=0.002, po0.001),
WIQ stairs (b=0.003, p=0.010), and WELCH total (b=0.004,
p=0.026) scores.
’ DISCUSSION
The main findings of this study were that usual and fast
gait speeds were moderately associated with objective and
subjective measurements of physical function in sympto-
matic PAD patients. After adjusting for age, ABI, BMI, and
gender, the usual gait speed was associated with the 6MWT,
sit-to-stand test and WIQ stairs scores, while the fast gait
speed was associated with the 6MWT, WIQ stairs and
WELCH total scores.
Despite the potential utility of the 4-meter gait speed test
in symptomatic patients with PAD, little information is
available regarding the differences between usual or fast gait
speed assessments. A previous study showed that fast gait
speed is a better predictor of functional decline than usual
gait speed, not only in patients with PAD with severe and
mild-to moderate intermittent claudication symptoms but
also in their peers without the disease (12). In the present
study, both modes of gait speed assessments were associated
with the 6MWT, with similar magnitude (usual gait: b=0.404
and fast gait: b=0.406).
In the elderly population, age-related loss of strength and
muscle mass are one factor causing a decline in gait speed
(19-21). In PAD patients, a correlation between leg strength
and walking capacity has been reported (2), and the changes
in walking capacity with resistance training were related to
changes in strength (22). Therefore, assessments of muscle
strength are important for patients with PAD. Usual gait
speed was related to scores on the sit-to-stand test and WIQ
stairs, which are highly dependent on muscle strength. These
results expand our current knowledge, indicating that in
addition to the 6MWT, gait speed assessed with a 4-meter
walk test can also provide information regarding lower limb
strength.
The results of the present study indicated that only fast
gait speed was associated with WELCH score, a score on a
specific questionnaire for PAD patients that accesses walking
impairment. In contrast to other questionnaires, the WELCH
Table 1 - Characteristics of the intermittent claudication
patients included in the study.
Variables Values (n=169)
Gender, % men 69
Age, years 66.6±9.4
Body mass index, kg/m2 27.6±4.7
Ankle brachial index 0.58±0.16
Risk factors
Diabetes mellitus, % 52
Hypertension, % 85
Dyslipidemia, % 78
Obesity, % 27
Coronary artery disease, % 34
Functional capacity
Usual gait speed, m/s 0.99±0.23
Fast gait speed, m/s 1.53±0.48
Claudication onset distance, m 135±74
Six-minute walk distance, m 338±83
Balance test, score 3.3±1.0
Chair stand test, s 15.5±7.1
Handgrip strength, kgf 32.6±11.8
Specific PAD questionnaires
WIQ distance, score 23.1±21.0
WIQ speed, score 23.5±15.2
WIQ stairs, score 31.3±24.6
WELCH total, score 28.3±19.6
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questionnaire is based on comparisons of peers of the same
age. A similar or greater ambulation compared to that of
peers is indicated by a higher score in the questionnaire.
The association between fast gait speed and WELCH score
reveals that the patients who walk faster believe their gait
speed to be similar to or better than that of their peers.
This association reveals that fast gait speed assessment can
also provide information regarding the self-perception of
the walking impairment caused by PAD, a relevant clinical
outcome for these patients.
From a practical point of view, the results of this study
indicated that in symptomatic PAD patients, usual and fast
gait speeds assessed with a 4-meter walk test are related to
different components of physical function. However, the
observed relationships were lower than r=0.55, indicating a
coefficient of explanation lower than 30%. Therefore, despite
the significant correlations, gait speed assessed with the
4-meter walk test is not an adequate substitute for the
objective and subjective functional tests.
This study presented some limitations. The main variable
of the present study was obtained with a manual stopwatch
(within 0.1 seconds). The sample included only patients with
symptomatic PAD, and these results cannot be extrapolated
to other stages of the disease, such as asymptomatic patients
and critical limb ischemia.
In conclusion, the usual and fast gait speeds assessed
with the 4-meter test were moderately associated with
objective and subjective measurements of physical function
in symptomatic PAD patients. Therefore, despite the sig-
nificant correlations, gait speed assessed with the 4-meter
walk test cannot be a substitute for objective and subjective
functional tests.
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